Christopher P. Lowe - 16 Aug 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Signature
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Issuer symbol
QNCX
Transactions as of
16 Aug 2021
Net transactions value
-$1,980,819
Form type
4
Filing time
18 Aug 2021, 17:25:23 UTC
Previous filing
30 Jun 2021
Next filing
07 Oct 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $49,060 +22,000 +73% $2.23 52,000 16 Aug 2021 Direct
transaction QNCX Common Stock Sale $862,958 -9,158 -18% $94.23 42,842 16 Aug 2021 Direct F1, F2
transaction QNCX Common Stock Sale $696,972 -7,335 -17% $95.02 35,507 16 Aug 2021 Direct F1, F3
transaction QNCX Common Stock Sale $224,426 -2,330 -6.6% $96.32 33,177 16 Aug 2021 Direct F1, F4
transaction QNCX Common Stock Sale $107,008 -1,100 -3.3% $97.28 32,077 16 Aug 2021 Direct F1, F5
transaction QNCX Common Stock Sale $205,415 -2,077 -6.5% $98.90* 30,000 16 Aug 2021 Direct F1
transaction QNCX Common Stock Options Exercise $66,900 +30,000 +100% $2.23 60,000 17 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Options Exercise $0 -22,000 -12% $0.000000 163,294 16 Aug 2021 Common Stock 22,000 $2.23 Direct F6
transaction QNCX Stock Option (right to buy) Options Exercise $0 -30,000 -18% $0.000000 133,294 17 Aug 2021 Common Stock 30,000 $2.23 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.63 to $94.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.66 to $95.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.68 to $96.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.89 to $97.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The option vested as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.